June 28, 2011. National Research Center of Women & Families President Diana Zuckerman testifies at the FDA meeting on Avastin.
Read More »On Medical Treatments & Products
NCHR Testimony at a House of Representatives Briefing on Medical Devices
May 17, 2011. Lives could be saved and patients would spend less time in the hospital if the FDA implemented the law as required by using the PMA process for all devices that are potentially dangerous in predictable ways.
Read More »Circulatory System Devices Panel Meeting: Slide Presentation
January 25, 2011. Researchers have reported that more than 20 percent of the almost one million AEDs in circulation were recalled by the FDA. Hundreds of people have died due to AED malfunctions. Innovation in design isn’t worth anything if the product doesn’t work when needed.
Read More »NCHR Testimony at the FDA on NB (Contrave)
December 7, 2010. FDA Advisory Committee members often ask for post-market studies. In this case, that could be dangerous.
Read More »Testimony at FDA on Gastric LAP-BAND
December 3, 2010. My name is Jessica Resas, and I am a lap band patient. In October of 2009, I had a lap band inserted inside me. Now I want my life back.
Read More »